Health Technology Assessment World Europe 2012

The most influential meeting on HTA for pharmaceutical products

At Health Technology Assessment World Europe thought leaders in HTA from leading biopharmaceutical companies, government agencies, academic institutions, contract service organisations and consultancies, will convene to discuss pioneering HTA strategy.

We have representatives from all the major HTA agencies as well as experts from the key pharma companies like Bayer Pharma, Novo Nordisk and Novartis.

• Keynote Speakers

Lizzie Amis,Pippa Anderson,Elise Berliner Ph.D.,Meindert Boysen,Dr. Anna Bucsics,Paul Catchpole PhD and many more.

Come to Health Technology Assessment World and learn:

• HTA policy and practice in Europe, USA and rest of the World

• HTA in reimbursement decisions

•Cooperation between regulatory bodies and HTA agencies

• How to demonstrate comparative effectiveness and outcomes research

• Case studies of HTA policy, practice and assessment methods

• HTA for speciality and high priced drugs

• Value based pricing, risk sharing schemes and reimbursement

• Role of patients in HTA

Who should attend:

This event will be attended by pharmaceutical and biotech professionals working in the following departments:

• HTA

• Market Access

• Health Economics

• Outcomes Research

• Health Policy

• Epidemiology

• Reimbursement

• Pricing

• Pharmacoeconomics